1. CSIG-10. GENOTYPE – KINOME GUIDED DEVELOPMENT OF PRECISION EGFR-TARGETED THERAPEUTICS FOR GLIOBLASTOMA. (9th November 2020) Authors: Smithberger, Erin; Shelton, Abigail; Butler, Madison; Stamper, Allie; Bash, Ryan; Angus, Steven; East, Michael; Johnson, Gary; Berens, Michael; Furnari, Frank; Miller, C Ryan Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DDRE-24. ACQUIRED RESISTANCE TO TARGETED INHIBITORS IN EGFR-DRIVEN GLIOBLASTOMA: IDENTIFICATION OF DUAL KINASE TARGETS. (9th November 2020) Authors: Shelton, Abigail; Smithberger, Erin; Butler, Madison; Stamper, Allie; Bash, Ryan; Angus, Steven; East, Mike; Johnson, Gary; Berens, Michael; Furnari, Frank; Miller, C Ryan Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DRES-07. DEFINING THE MECHANISMS OF ACQUIRED RESISTANCE TO TYROSINE KINASE INHIBITORS IN EGFR-DRIVEN GLIOBLASTOMAS USING INTEGRATED KINOME AND TRANSCRIPTOME PROFILING. (5th November 2018) Authors: Shelton, Abigail; Smithberger, Erin; Butler, Madison; Flores, Alex; Bash, Ryan; Angus, Steven; Sciaky, Noah; Dhruv, Harshil; Johnson, Gary; Berens, Michael; Furnari, Frank; Miller, Ryan Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DRES-13. DUAL KINASE INHIBITION TO COMBAT EGFR-INHIBITOR RESISTANCE IN GLIOBLASTOMA. (11th November 2019) Authors: Smithberger, Erin; Shelton, Abigail; Butler, Madison; Flores, Alex; Bash, Ryan; Angus, Steven; East, Michael; Sciaky, Noah; Dhruv, Harshil; Johnson, Gary; Berens, Michael; Furnari, Frank; Ryan Miller, C Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EXTH-03. COMBINED TOP1 AND PARP INHIBITION ENFORCES GENOMIC INSTABILITY AND CELL DEATH IN PTEN-DEFICIENT GLIOBLASTOMA. (12th November 2021) Authors: Kim, Olga; Butler, Madison; Pang, Ying; Yu, Guangyang; Merchant, Mythili; Ranjan, Alice; Gilbert, Mark; Pommier, Yves; Wu, Jing Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EXTH-44. INHIBITION OF MerTK ACTIVATES GLIOBLASTOMA-ASSOCIATED MACROPHAGES AND INDUCES TUMOR CELL DEATH IN GLIOMA MICROENVIRONMENT. (11th November 2019) Authors: Su, Yu-Ting; Butler, Madison; Hwang, Lee; Maric, Dragan; Earp, Shelton; Terabe, Masaki; Gilbert, Mark; Wu, Jing Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EXTH-58. INHIBITION OF DNA TOPOISOMERASE 1 AND POLY(ADP-RIBOSE) POLYMERASE SYNERGISTICALLY INDUCES CELL DEATH IN GLIOBLASTOMA WITH PTEN LOSS. (11th November 2019) Authors: Butler, Madison; Su, Yu-Ting; Hwang, Lee; Marzi, Laetitia; Gilbert, Mark; Pommier, Yves; Wu, Jing Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EXTH-63. COMBINED INHIBITION OF TOP1 AND PARP: A NOVEL THERAPEUTIC STRATEGY FOR GBM WITH PTEN DEFICIENCY. (14th November 2022) Authors: Kim, Olga; Butler, Madison; Robey, Robert; Chari, Raj; Sergi, Zach; Zhang, Meili; Pang, Ying; Yu, Guangyang; Zhang, Wei; Song, Hua; Davis, Dionne; Wang, Herui; Merchant, Mythili; Ranjan, Alice; Gilbert, Mark; Gottesman, Michael; Pommier, Yves; Wu, Jing Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment. Issue 1 (3rd June 2020) Authors: Su, Yu-Ting; Butler, Madison; Zhang, Meili; Zhang, Wei; Song, Hua; Hwang, Lee; Tran, Andy D; Bash, Ryan E; Schorzman, Allison N; Pang, Ying; Yu, Guangyang; Zamboni, William C; Wang, Xiaodong; Frye, Stephen V; Miller, Christopher Ryan; Maric, Dragan; Terabe, Masaki; Gilbert, Mark R; Earp III, Henr... Journal: Neuro-oncology advances Issue: Volume 2:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Report of Canonical BCR-ABL1 Fusion in Glioblastoma. (2021) Authors: Pang, Ying; Yu, Guangyang; Butler, Madison; Sindiri, Sivasish; Song, Young K.; Wei, Jun S.; Wen, Xinyu; Chou, Hisen-Chao; Quezado, Martha; Pack, Svetlana; Xi, Liqiang; Abdullaev, Zied; Kim, Olga; Ranjan, Alice; Merchant, Mythili; Antony, Ramya; Boris, Lisa; Aboud, Orwa; Kamson, David; Kaplan, Ros... Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗